New Fund
San Sebastián and Barcelona, Spain-based Ysios Capital launched a €100m target fund to back biotech via technology transfer and early-stage company creation, translating high-quality science—particularly in Spain—into new therapies.
London-based AP Ventures closed $300M Fund III to invest in early-stage...
Stockholm, Sweden-based BackingMinds secured a €50M first close to back...
Barcelona-based Masia closed its first fund at €18M to back early-stage...
Spain- and UK-based Nauta Capital secured a €60m first close to invest...
London, UK-based TSP Ventures closed an undisclosed amount to back...
Milan, Italy-based Panakès Partners raised €8.5M to back Lombardy-based...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
